Overview
The PDip in Pharmaceutical and Biopharmaceutical Engineering is offered in both part-time and full-time mode. While the part-time programme runs for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme , full-time students must complete the programme in 12 months.
This course provides the opportunity to gain a formal qualification in areas of particular relevance to the pharmaceutical and biopharmaceutical industry; to upskill one's competence for these important industrial sectors, including topics such as product containment, powder/particle technology, design of API and secondary production facilities, current Good Manufacturing Practice (cGMP), design of classified facilities, aseptic processing facility design, utilities, and services, data analysis and process validation.
Individual Modules or Micro-Credits
Candidates who satisfy the programme eligibility criteria may, subject to the approval of the Programme Coordinator, be permitted to take individual modules, as part of UCC's commitment to Continuing Professional Development (CPD), and be provided with a relevant transcript of marks.
MEngSc in Pharmaceutical and Biopharmaceutical Engineering
Students who pass all modules with an average grade of 50% or higher across the taught modules will be eligible to proceed to MEngSc in Pharmaceutical and Biopharmaceutical Engineering.
Programme Requirements
For information about modules, module choice, options and credit weightings, please go to Programme Requirements.
Programme Requirements
The programme comprises 60 credits of taught modules.
Module List
| Code |
Title |
Credits |
| 45 |
| |
| Pharmaceutical Engineering (5) | |
| Biopharmaceutical Engineering (5) | |
| Pharmaceutical Process Equipment, Materials and Mechanical Design (5) | |
| Powder and Particle Technology and Unit Operations (5) | |
| Advanced Biopharmaceutical Engineering (5) | |
| Process Optimisation in the Pharmaceutical Industry (5) | |
| Aseptic Manufacturing Design (5) | |
| Process Safety Engineering (5) | |
| Project Engineering - From Concept to Completion (5) | |
| |
| 15 |
| Pharmaceutical Process Validation and Quality (5) | |
| Process Analytical Technology (5) | |
| Biopharmaceutical Supporting Systems (5) | |
| Introductory Pharmaceutical Chemistry (5) | |
Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards Book and for each module in the Book of Modules.
Programme Learning Outcomes
Programme Learning Outcomes for Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:
1
1-1
Apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering;
1-2
2
Identify, formulate, analyse and solve problems related to pharmaceutical and biopharmaceutical engineering;
1-3
3
Design pharmaceutical and biopharmaceutical manufacturing facilities and processes, including unfamiliar, ill-defined scenarios, underpinned by a sustainability informed paradigm, taking account of environmental, health and safety and risk factors, and know how to apply relevant codes of practice, industry standards and emerging practices and technologies;
1-4
4
Gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
1-5
5
Effectively design experiments and gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
1-6
6
Work effectively as an individual and in teams in planning and carrying through on assignments and projects in a lifelong learning context;
1-7
7
Communicate effectively with the engineering community and with society at large.
